Exelixis, Inc. (EXEL)
56.78
-0.12
(-0.21%)
USD |
NASDAQ |
Sep 16, 16:00
56.78
0.00 (0.00%)
After-Hours: 20:00
Exelixis Total Return Level : 56.78 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 56.78 |
| September 15, 2026 | 56.90 |
| September 14, 2026 | 56.21 |
| September 11, 2026 | 56.12 |
| September 10, 2026 | 57.43 |
| September 09, 2026 | 58.33 |
| September 08, 2026 | 57.67 |
| September 04, 2026 | 59.01 |
| September 03, 2026 | 59.13 |
| September 02, 2026 | 58.53 |
| September 01, 2026 | 56.89 |
| August 31, 2026 | 54.64 |
| August 28, 2026 | 54.45 |
| August 27, 2026 | 55.26 |
| August 26, 2026 | 56.10 |
| August 25, 2026 | 56.72 |
| August 24, 2026 | 54.55 |
| August 21, 2026 | 54.08 |
| August 20, 2026 | 53.69 |
| August 19, 2026 | 54.39 |
| August 18, 2026 | 53.12 |
| August 17, 2026 | 52.32 |
| August 14, 2026 | 51.24 |
| August 13, 2026 | 50.61 |
| August 12, 2026 | 50.38 |
| Date | Value |
|---|---|
| August 11, 2026 | 51.33 |
| August 10, 2026 | 52.96 |
| August 07, 2026 | 54.07 |
| August 06, 2026 | 52.20 |
| August 05, 2026 | 56.70 |
| August 04, 2026 | 56.00 |
| August 03, 2026 | 55.06 |
| July 31, 2026 | 53.03 |
| July 30, 2026 | 55.97 |
| July 29, 2026 | 55.33 |
| July 28, 2026 | 56.51 |
| July 27, 2026 | 55.81 |
| July 24, 2026 | 55.37 |
| July 23, 2026 | 55.65 |
| July 22, 2026 | 54.98 |
| July 21, 2026 | 56.12 |
| July 20, 2026 | 55.53 |
| July 17, 2026 | 55.92 |
| July 16, 2026 | 55.68 |
| July 15, 2026 | 55.55 |
| July 14, 2026 | 55.77 |
| July 13, 2026 | 56.04 |
| July 10, 2026 | 56.50 |
| July 09, 2026 | 57.10 |
| July 08, 2026 | 56.11 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 239.36 |
| BioMarin Pharmaceutical, Inc. | 64.73 |
| Cytokinetics, Inc. | 69.39 |
| Emergent BioSolutions, Inc. | 6.75 |
| Gilead Sciences, Inc. | 216.44 |